Komatsu, Masaaki 1) 利用者は、事前に承諾者から承諾を得ること。 2) 利用者が本件リソースを使用して得られた研究成果に基づき特許の申請、及び事業活動を行う場合は、承諾者と別途協議を行う。 3) 利用者は、研究成果の公表にあたって寄託者の指定する文献 (Mol Biol Cell. 2008;19:4762-75) を引用すること。 4) 利用者は、研究成果の公表にあたって謝辞の表明を必要とする。 Komatsu, Masaaki マウス胎児由来線維芽細胞株。C57BL/6系統由来。 Atg3 +/+ MEFs RCB3708 Mouse embryonic fibroblast cell line derived from wild type C57BL/6 strain. 1) The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the approver. 2) The RECIPIENT must contact the DEVELOPER in case of application for any patents or commercial use with the results from the use of BIOLOGICAL RESOURCE. 3) In publishing research results obtained by the use of the BIOLOGICAL RESOURCE, a citation of the literature ref. (Mol Biol Cell. 2008;19:4762-75) designated by the DEPOSITOR is required. 4) In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. 5) The RECIPIENT of BIOLOGICAL RESOURCE who belongs to a profit organization must obtain a prior written consent on use of it from the DEPOSITOR.